SMRT Central Office
2030 Addison Street
7th Floor
Berkeley, CA  94704
Tel:  +1 510-841-1899
Fax:  +1 510-841-2340

SMRT Educational Seminars
Safety & Screening in MRI
Volume 14, Number 4
The SMRT Educational Seminars (Volume 14, Number 4), has been approved for 2.5 Category A Continuing Educational credits.

Read the SMRT Educational Seminars (Volume 14, Number 4), "Safety & Screening in MRI" and complete the quiz and official Answer Form at the back of the article. To receive credit the quiz must be completed with a score of 75% or better. Completion of all questions with a passing score will earn a total of 2.5 category A Continuing Education credits.
SMRT members should send the completed Answer Form to the SMRT Education Department for scoring. The certificate will state the CE reference number and awarded CE credits. Members receiving a score less than 75% will be notified and given the option of taking the quiz an additional two times. Members should retain their CE Certificate for their Continuing Education registry requirements.
Educational Objectives
Focus on MR Patient Care, Safety and Contrast Administration
  • Review the main magnetic field and its potential biological effects;
  • Describe Specific Absorption Rate (SAR) and its considerations for MR safety;
  • Discuss the gradients fields rate of change and potential issues;
  • Explain the concerns for patient safety regarding acoustic noise and sound pressure levels;
  • Review general MR safety considerations, policies and procedures;
  • Describe the concerns surrounding medical equipment used in the MR environment;
  • Explain the ‘four zones’ of safety in MR suite design;
  • Review patient safety including screening, foreign bodies, pacemakers, aneurysm clips and vascular stents;
  • Discuss recent change in MR safety terminology for implants and devices;
  • Review other patient safety concerns in the MR environment including claustrophobia, medical emergency, pregnancy and infectious diseases; and
  • Describe the potential issues surrounding MR contrast administration including reactions, extravasation, pregnancy and breastfeeding.

MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis

  • Review NSF including facts, hypotheses, preventative measures, and diagnosis;
  • Explain the anatomy and physiology affected by NSF;
  • Show pictures of the various changes and stages of NSF;
  • Explore potential causes of NSF including tissue deposition of gadolinium;
  • Discuss the molecular makeup and stability of each of the gadolinium-based contrast agents; and
  • List the steps necessary to minimize the risk of NSF.

MRI Safety Update 2008: Part 2, Screening Patients for MRI

  • Discuss the safety screening of patients for MRI procedures and individuals entering the MRI environment;
  • Show an example of a comprehensive MRI pre-procedure screening form (in English and Spanish) for patients and explain its use;
  • Show an example of a limited MRI screening form used for individuals (not patients) to allow their safe entry into the MRI environment; and
  • Review information for new or controversial implants and devices including, among many, ActiPatch, Foley catheter with temperature sensor, glaucoma drainage implants, hemostatic vascular clips, and PillCam.